Bart I. Keymeulen
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Markers of beta cell and alpha cell mass in human stem cell-generated implants with glycemic control at human setpoint.
Journal: Stem cells translational medicine
Published: January 21, 2026
Psychosocial aspects in diabetes care: An observational study at an outpatient academic diabetes specialist centre in a metropolitan capital.
Journal: Patient education and counseling
Published: January 14, 2026
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes.
Journal: Diabetes technology & therapeutics
Published: December 30, 2025
Non-HLA Risk Loci ERBB3/IKZF4 and ERBB2/IKZF3/GSDMB/ORMDL3 Interact to Influence Progression of Autoimmunity in Relatives of T1D Patients.
Journal: Diabetes/metabolism research and reviews
Published: December 17, 2025
One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study.
Journal: Diabetologia
Published: December 02, 2024
Repeated OGTT Versus Continuous Glucose Monitoring for Predicting Development of Stage 3 Type 1 Diabetes: A Longitudinal Analysis.
Journal: Diabetes care
Published: October 30, 2024
Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands: a population-based retrospective cohort study.
Journal: ESMO open
Published: December 01, 2023
Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetes.
Journal: Diabetes research and clinical practice
Published: May 10, 2023
Last Updated: 09/26/2026